News for FUJIFILM Holdings Corporation (4901.T)

Lexington, MA, and Las Vegas, NV, March 03, 2025 (GLOBE NEWSWIRE) -- FUJIFILM Healthcare Americas Corporation, a leading provider of enterprise imaging and informatics solutions, today announced a new strategic partnership with Tiger Health Technology, a leading provider of hybrid cloud solutions, to optimize data lifecycle management and address key storage-related challenges in digital pathology.

Lexington, MA, and Las Vegas, NV, March 03, 2025 (GLOBE NEWSWIRE) —

TOKYO, February 5, 2025 -- FUJIFILM Corporation today announced that it will install new production facilities of CMP slurries*1, advanced semic...

- 4K-compatible model of ultra-short-throw projector equipped with industry's only “folded two-axial rotatable lens” - Creating immersive v...

Contributing to early detection of cancer and lifestyle diseases by incorporating Fujifilm’s expertise in managing health screening centerTOKYO,...

High-end model designed to make every shot a masterpiece with its extensive range of effects Introducing new WIDE format film “BRUSHED METALLICS...

- Combining a powerful image stabilization system and the highest magnification in the series - Allowing for brighter and clearer observation of...

The Instant Evo-lution Continues: Fujifilm Introduces instax WIDE Evo™ Hybrid Instant Camera

**media[516339]**

**media[510763]**

Comprehensive hub combines health screenings with medical staff training and remote image interpretationTOKYO, December 24, 2024 -- FUJIFILM Cor...

TOKYO - December 6, 2024 — FUJIFILM Corporation today announced that it will enhance its production capacity of CMP slurries*1, advanced semico...

**media[477509]**

**media[476873]**

**media[472076,472077,472078]**

The Lung Cancer Screening Market Size sector reached a market value of USD 3.28 Billion in 2023. Future projections show a bright outlook, with a Compound Annual Growth Rate (CAGR) of 9.1% from 2023…

Pyrogen testing industry is projected to witness a CAGR of 9.1% during the period 2024-2032. This growth can be attributed to the growing investment in...

Global Fertility Testing Devices Market Size Was Valued at USD 702.59 Million In 2023 And Is Projected to Reach USD 1171.55 Million By 2032, Growing at A...

The Increasing Prevalence of Chronic Diseases, Advancements in Imaging Technologies, and Rising Importance of Early Disease Diagnosis are Presently Driving...